What is Celldex Therapeutics's net change in cash?

Celldex Therapeutics (CLDX) reported net change in cash of $6.86M in Q1 2026.

How has Celldex Therapeutics's net change in cash changed year-over-year?

Celldex Therapeutics's net change in cash increased by 161.1% year-over-year, from -$11.22M to $6.86M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Celldex Therapeutics CLDX Net Change in Cash

Net Change in Cash at other companies

Eli LillyLLY

-$1.99B-1,035%

PfizerPFE

$563M+50.1%

Rogers CorporationROG

-$1.2M-108%

AmgenAMGN

$2.91B+192%

Regeneron PharmaceuticalsREGN

-$153.1M-125%

IncyteINCY

$363.28M+43.1%

Other financials

Income statement

See full

Revenue$15.0K-97.8%

Operating income-$84.4M-34.6%

Net income-$78.7M-46.3%

EPS (diluted)-$1.18-45.7%

Balance sheet

See full

Cash & equivalents$35.7M+109%

Total debt$1.9M-44.3%

Total equity$456.2M-35.1%

Total assets$511.3M-30.9%

Cash flow

See full

Operating cash flow-$65.6M-20.6%

CapEx$1.6M+518%

Free cash flow-$67.2M-23.0%

Valuation

See full

Market cap$2.59B+75.2%

Enterprise value$2.55B+74.4%

P/S2,989.2×+2,794×

Profitability

See full

Operating margin-35,688.5%-39,114pp

Net margin-32,753.6%-35,519pp

FCF margin-26,125.8%-28,907pp

Returns & leverage

See full

Return on equity-48.9%-498pp

Debt / equity0×0.0×

Current ratio8.9×-12.7×

Where this comes from

Reported directly by Celldex Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Celldex Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celldex Therapeutics's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Celldex Therapeutics's net change in cash?: Celldex Therapeutics (CLDX) reported net change in cash of $6.86M in Q1 2026.
How has Celldex Therapeutics's net change in cash changed year-over-year?: Celldex Therapeutics's net change in cash increased by 161.1% year-over-year, from -$11.22M to $6.86M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.